ICD-10 Coding for Elevated Parathyroid Hormone(E21.0, E21.0B, E21.0P)
Explore the ICD-10 coding for elevated parathyroid hormone, including primary and secondary hyperparathyroidism. Learn about documentation requirements and coding pitfalls.
Complete code families applicable to Elevated Parathyroid Hormone
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E21.0 | Primary hyperparathyroidism | Use when hypercalcemia and elevated PTH are confirmed with imaging or lab tests indicating parathyroid adenoma or hyperplasia. |
|
| E21.1 | Secondary hyperparathyroidism, not elsewhere classified | Use when secondary causes such as vitamin D deficiency are documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutElevated Parathyroid Hormone
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Elevated Parathyroid Hormone.
Failing to specify the type of hyperparathyroidism.
Impact
Clinical: May lead to inappropriate treatment plans., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims.
Mitigation
Ensure documentation includes specific type and cause., Use decision trees for code selection.
Using unspecified codes like E21.3 without justification.
Impact
Reimbursement: May lead to reduced reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of health records.
Mitigation
Ensure documentation specifies the type of hyperparathyroidism.
Use of unspecified codes
Impact
High risk of audit if unspecified codes are used without justification.
Mitigation
Ensure documentation clearly specifies the type of hyperparathyroidism.